552 related articles for article (PubMed ID: 7506736)
1. Taxol provides a second signal for murine macrophage tumoricidal activity.
Manthey CL; Perera PY; Salkowski CA; Vogel SN
J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
Jun CD; Yoon HJ; Kim HM; Chung HT
Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
4. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
[TBL] [Abstract][Full Text] [Related]
6. Involvement of protein kinase C during taxol-induced activation of murine peritoneal macrophages.
Jun CD; Choi BM; Kim HM; Chung HT
J Immunol; 1995 Jun; 154(12):6541-7. PubMed ID: 7759887
[TBL] [Abstract][Full Text] [Related]
7. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages.
Dong Z; Qi X; Xie K; Fidler IJ
J Immunol; 1993 Sep; 151(5):2717-24. PubMed ID: 7689614
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide and ceramide use divergent signaling pathways to induce cell death in murine macrophages.
Lakics V; Vogel SN
J Immunol; 1998 Sep; 161(5):2490-500. PubMed ID: 9725248
[TBL] [Abstract][Full Text] [Related]
10. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
11. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed, C3H/HeJ macrophages to a fully tumoricidal state.
Hogan MM; Vogel SN
J Immunol; 1987 Dec; 139(11):3697-702. PubMed ID: 3119714
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
[TBL] [Abstract][Full Text] [Related]
13. Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells.
Kim YM; Paik SG
Biochem Biophys Res Commun; 2005 Jan; 326(2):410-6. PubMed ID: 15582593
[TBL] [Abstract][Full Text] [Related]
14. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM
Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway.
Paulnock DM; Lambert LE
J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of macrophage tumoricidal activity by glucocorticoids.
Hogan MM; Vogel SN
J Immunol; 1988 Jan; 140(2):513-9. PubMed ID: 3121748
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
18. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
19. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells].
Akiyama Y; Yamasaki T; Fukuda M; Moritake K
No To Shinkei; 1995 Apr; 47(4):349-55. PubMed ID: 7772402
[TBL] [Abstract][Full Text] [Related]
20. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.
Klostergaard J; Leroux ME; Hung MC
J Immunol; 1991 Oct; 147(8):2802-8. PubMed ID: 1918993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
